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Abstract 
Background: The factors leading to poor outcomes in malaria infection are incompletely understood. Common 
genetic variation exists in the human genes for Toll like receptors (TLRs) that alter host responses to pathogen‑
associated molecular patterns. Genetic variation in TLR1 and TLR6 could alter the risk of development of complicated 
malaria and ability of the host to control the parasite burden during acute Plasmodium falciparum infection.
Methods: Five single nucleotide polymorphisms in TLR1 and TLR6 in 432 patients with clinical P. falciparum monoin‑
fection acquired on the Thai‑Myanmar border were genotyped. Using logistic regression, associations with the devel‑
opment of complicated malaria and the percentage of infected erythrocytes (parasitaemia) on the day of presenta‑
tion to clinical care (day zero) were tested.
Results: Genotypes carrying the T (major) allele of TLR1 rs5743551—an allele associated with improved outcomes in 
sepsis—were associated with higher parasitaemia measured on day zero (p = 0.03).
Discussion: Since malaria exerts strong genetic pressure on the human genome, protection from parasitaemia asso‑
ciated with TLR1 rs5743551 may account for the maintenance of an allele associated with poor outcomes in Cauca‑
sians with sepsis.
Conclusion: These data suggest that genetic variation in TLR1 has effects on the host response to Plasmodium falci-
parum malaria in Asian populations. Genotypes from TLR6 showed no evidence of association with either complicated 
malaria or parasite burden.
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Parasitaemia
© 2016 Hahn et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Malaria is estimated to cause approximately 850,000 
deaths per year with most mortality occurring before 
the age of 5  years [1]. Since death occurs prior to the 
age of reproduction, the malaria parasite is thought to 
exert strong selective pressure on the human genome. 
The clearest example is the sickle cell trait where the 
heterozygote state provides protection against malaria 
whereas homozygosity for sickle cell trait (sickle cell 
disease) is uniformly fatal. The high prevalence of sev-
eral independently arising alleles causing sickle cell trait 
in different populations implies a strong selective pres-
sure on the human genome [2]. While the immunologic 
host determinants of susceptibility to malaria remain 
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incompletely understood, family-based longitudinal 
studies have demonstrated that susceptibility to clinical 
malaria is partially heritable [3].
The role of innate immunity and, specifically, innate 
immune responses in host defence against malaria has 
been reviewed previously [4]. Common genetic varia-
tions in TLR genes have been associated with disease 
susceptibility in humans to a wide variety of pathogens 
[5]. Polymorphisms in innate sensing pathways have 
also been implicated in host susceptibility to malaria [6]. 
There are several components of the malaria parasite that 
have been implicated as pathogen-associated molecular 
patterns (PAMPs) recognizable by the innate immune 
system, including glycosylphosphatidylinositol (GPI) 
anchors on the surface membranes of infected red blood 
cells (RBCs) and DNA-haemozoin complexes within the 
cytoplasm [7, 8]. GPI initiated signals are thought occur 
via TLR1/2 or TLR2/TLR-6 heterodimers and DNA-
hemozoin complexes via TLR9 [8–10]. TLR1 is part of a 
complex of TLR receptors that includes TLR1, TLR6, and 
TLR10, and is thought to have arisen via a gene duplica-
tion event [11].
Since Plasmodium is a well-described cause of the sep-
sis syndrome, the possible contribution of TLR polymor-
phisms to clinical outcomes in malaria also has potential 
explanatory power [12, 13]. In a cohort of patients with 
sepsis and septic shock from an area with no ongo-
ing malaria transmission, it has been shown that com-
mon variation in the gene for TLR1, the G (minor) allele 
of TLR17202A/G (rs5743551) is associated with a large 
increase in the severity of organ dysfunction and an 
increased risk of death [14]. Others have observed similar 
biologic effects of this hyperfunctional variant and have 
shown this allele to be associated with increased risk for 
clinical tuberculosis, leprosy and frequency of leprosy 
reversal reactions [15, 16]. The minor allele of TLR17202A/G 
has been also been associated with increased Interleu-
kin-6 (IL-6) production and decreased regulatory T cell 
(CD4+, CD25+) mediated suppression of proliferation 
utilizing in  vitro culture systems [17]. The TLR17202A/G 
(minor allele) is a non-coding SNP that sits within the 
5′ upstream region of the TLR1 gene and, thus, cannot 
have a direct effect on TLR1 protein function. It has been 
previously demonstrated, however, that the rs5743551 
SNP is associated with increased secretion of soluble 
mediators of inflammation in response to stimulation 
with Pam3CysSerLys4 (Pam3CSK4), a specific ligand for 
TLR1/TLR2 heterodimers [14]. One potential explana-
tion for the observed hyper responsiveness is that TLR1 
rs5743551 is in LD with several coding polymorphisms 
that strongly increase cell surface expression of TLR1.
These data suggest that polymorphisms in TLR1 have 
functional consequences in immunologic signalling and 
influence the host response to a broad range of microbial 
pathogens. Given the potential role of TLR1 in inflam-
matory responses to malaria, it was hypothesized that 
the presence of the minor TLR1A7202G allele would be 




Patients (age >13 years) were enrolled from a population 
presenting with febrile illness to clinical sites for Hospital 
for Tropical Disease (Mahidol University) on the Thai-
Myanmar border found to be infected with Plasmodium 
falciparum malaria. Study recruitment was from 2000–
2004, a period in which malaria was endemic. Patients 
were excluded if they had another plausible medical 
explanation for fever (e.g., lobar pneumonia). The age 
of 13 was selected as subjects were originally recruited 
to participate in a previously reported clinical trial [18]. 
Both thick and thin smears were performed on whole 
blood specimens from all patients. Enrolment occurred 
on the basis of unblinded smear microscopy, but this 
was confirmed with PCR (as previously described) [19]. 
Patients with mixed infections were excluded. Patients 
were initially classified into uncomplicated malaria (UM), 
severe malaria or cerebral malaria on the basis of WHO 
criteria [20].
An expert microscopist blinded to other diagnostic 
testing confirmed the presence of P. falciparum periph-
eral blood smear after enrolment and performed quan-
titation of the parasite. Species level infection was also 
confirmed with PCR as previously described [21]. Para-
site density was determined by counting the number of 
parasites per 200 white blood cells for thick blood films 
or per 1000 RBCs for thin blood films.
The institutional review board of the Faculty of Tropi-
cal Medicine, Mahidol University approved this study. 
Verbal and written explanations were provided in the 
patient’s’ native language, and informed consent was 
obtained from all patients or their legal guardians prior 
to specimen collection.
Genotyping
TLR1 (rs5743551, rs5743614, rs5743618) and TLR6 
(rs3775073, rs5743808) in the malaria cases were geno-
typed using Taqman-based real-time polymerase chain 
reaction (RT-PCR) as previously described [22]. Primer-
probe sets were obtained from the Applied Biosystems 
repository (TLR1−7202A/G) or synthesized (TLR11517G/A, for-
ward primer: AGCAGCCTTTCTGTATTGATCATTGA, 
reverse primer: CATCTTCTGGCAGCTCTGGAA, 
probe: CACCCATC[G/A]GCTGAT; TLR11804G/T, for-
ward primer: GGTGTTGGCTGTGACTGTGA, reverse 
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primer: GCACACCATCCTGAGATACCA, probe: CCT 
CTGCA[G/T]CTACTT) and run according to the rec-
ommended guidelines on an ABI Prism 7900HT (Applied 
Biosystems, Inc., Foster City, CA, USA). 2 % of the samples 
were replicated for quality control.
Statistical analysis
The two phenotypes tested for association with TLR1 and 
TLR6 genotypes were:
(1) Complicated malaria disease versus uncomplicated 
disease, and (2) log10-transformed measurements of par-
asitaemia on day 0 for each subject. Observed genotype 
frequencies were compared with expected frequencies 
to test for deviations from Hardy–Weinberg equilibrium 
as previously described [23]. Inspection of the geno-
type frequencies by ethnicity revealed that patients 
that were self-declared “Karen” exhibited genotype fre-
quencies highly divergent from the other major ethnic 
groups (data not shown). Patients of Karen ethnicity 
were excluded to avoid confounding due coexistent but 
unrelated population-specific differences in genotype 
frequencies and phenotype prevalence. Cambodian 
and Nepali patients were also excluded due to very low 
population sizes. To identify associations between TLR1 
and TLR6 genotypes and the presence of complicated 
malaria in the Burmese, Mon, and Thai patients, logis-
tic regression was used, assuming an additive effect as 
previous work demonstrated an intermediate functional 
phenotype in heterozygotes [14]. To test for an associa-
tion between TLR1 and TLR6 genotypes and day 0 log10 
transformed parasitaemia, linear regression was used 
assuming an additive effect. For associations detected 
in the un-adjusted analyses, multiple linear regression 
analyses were performed adjusting for age and gender. 
Finally, to assess whether genotypic effects were con-
sistent across ethnic groups, sensitivity analyses were 
performed with stratification on the basis of each of the 
three major ethnic groups (Mon, Burmese, and Thai). 
Statistical significance was set at p < 0.05. Analyses were 
performed using Stata 10.0 (Stata Corp., College Station, 
TX, USA).
Results
TLR1 genotype frequency and susceptibility 
to complicated malaria
Common genetic variants within TLR1 and TLR6 are 
associated with altered innate immune responses to 
synthetic bacterial lipoproteins [14]. Functional genetic 
variation within TLR1 and TLR6 could therefore be 
associated with severity of malarial illness and/or the 
degree of parasitaemia observed in each patient on 
the day patients were diagnosed with clinical malaria. 
To test this hypothesis five different single nucleotide 
polymorphisms (SNPs) were genotyped, three in TLR1 
and two in TLR6 (Fig.  1), in a group of 435 patients 
enrolled in northern Thailand with PCR-confirmed infec-
tion with P. falciparum.
Self-reported race/ethnicity in the studied group 
revealed the existence of several populations with the 
majority of patients declaring Thai ancestry (41.8 %) fol-
lowed by Mon (29.0 %), Karen (16.3 %), Burmese (12.2 %), 
and, to a much lesser extent Cambodian and Nepali 
(Tables  1, 2). The patients were young with a mean age 
of 27 years. In terms of severity of illness, 59 % had UM 
while 19.8 % had cerebral malaria and 21.2 % had com-
plicated disease. Mean parasitaemia on day 0 was nearly 
80,000 parasites/uL and ranged from 13 to over 1 × 106 
parasites/uL. As expected, disease severity and parasitae-
mia were correlated. Mean parasitaemia in patients with 
cerebral or complicated malaria was roughly an order of 
magnitude higher than in patients with uncomplicated 
malaria (p  <  0.01) (Table  2). Given the relatively small 
number of patients with complicated disease and the 
assumption that TLR responses are likely to be an early 
event in malaria host defense within the causal pathway 
for both forms of complicated malaria, it was decided to 
pool cerebral and complicated malaria for the purposes 
of analysis. This approach is consistent with natural his-
tory studies in African children where severe clinical 
malaria exists as a series of overlapping syndromes rather 
than discrete clinical phenotypes [24].
Consistent with prior reports documenting this diver-
gence using other genetic markers, genotype frequencies 
for patients of Karen ethnicity were markedly different 
from other major ethnic groups and are divergent from 
frequencies observed in reference Asian populations [25, 
26]. This was not due to assay variability, as genotyping 
was successful with over 98  % of all genotypes called 
with excellent agreement between replicates (>99  %) 
and all genotype frequencies were found to be consistent 
with Hardy–Weinberg equilibrium. Given the likelihood 
that associations between TLR1 or TLR6 genotype fre-
quencies and malaria phenotypes would be confounded 
by major underlying population differences in genetic 
Fig. 1 Genetic maps of TLR1 and TLR6. Diagram shows the transcrip‑
tional orientation, exon/intron structure, intergenic distance and 
location of genotyped polymorphisms (dbSNP reference number, 
nucleotide alleles and amino acid alleles for coding variants) for TLR1 
and TLR6
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architecture, analyses for the Karen subjects were per-
formed separately from the other ethnic groups. Patients 
who self-reported Burmese, Mon, or Thai ethnicity were 
analysed as a group.
A trend towards an association between the “major” 
T allele of TLR1 rs5743551 (associated with less inflam-
matory responses in other systems) and susceptibil-
ity to complicated malaria [OR (CI) =  1.26 (0.93–1.71), 
p = 0.14, Table 3] was observed. When analysed within 
each ethnic group, all three groups (Burma, Mon, and 
Thai) exhibited trends of similar direction and magnitude 
but none met pre-specified criteria for statistical signifi-
cance (data not shown). No major trends were observed 
with any other polymorphism tested nor was there any 
significant association observed between any genotype 
and susceptibility to complicated malaria in subjects of 
Karen ethnicity.
TLR1−7202A/G is associated with elevated malaria 
parasitaemia
Associations between malaria parasitaemia measured 
on day 0 of enrollment and TLR1 and TLR6 genotypes 
were also tested. Table  3 shows an association between 
increasing copy number of the T-allele (major allele) of 
TLR1 rs5743551 and higher levels of parasitaemia. A 
nearly two-fold increase in mean parasitaemia in subjects 
carrying the “major” TT genotype relative to those car-
rying the “minor” GG genotype (Table 3) was observed. 
Notably, when analysed by ethnicity, all three major eth-
nic groups demonstrated a similar trend with the major 
allele with the strongest effect observed in subjects of 
Mon ethnicity (p  =  0.03) (Fig.  2). A similar trend was 
observed with TLR1 rs5743614 although this did not 
meet statistical significance. No other genotypes demon-
strated an association with parasitaemia. In addition, no 
genotypes were found to associate with day 0 parasitae-
mia in subjects of Karen ethnicity.
Discussion
Early host innate immune inflammatory responses 
are likely to play an important role in determining the 
clinical course after infection with P. falciparum. It was 
determined that TLR1 polymorphisms previously dem-
onstrated to be associated with functional changes in 
immunologic signaling were associated with different 
levels of host control of P. falciparum in patients with 
clinical malaria. In the studied patient population, the 
GG (minor) allele of rs5743551 was associated with a 
parasite density roughly half of that of patients with the 
TT (major) allele. The G (minor) allele has been associ-
ated with increased inflammatory cytokine production in 
response to bacterial lipopeptides that are recognized by 
TLR1/2 heterodimers [14]. The direction of this associa-
tion with the G (minor) allele in the studied population 
of patients with clinical malaria, however, is opposite the 
direction in sepsis patients where the presence of the T 
(major) allele was associated with improved clinical out-
comes. Furthermore, the density of the pathogen is dif-
ferent in patients with the G (minor) allele with respect to 
malaria and sepsis, as carriers of the minor G allele were 
more likely to have blood cultures with bacterial growth 
(a proxy for degree of bacterial burden) compared to car-
riers of the major T allele whereas the minor G allele was 
associated with fewer parasites per millilitre of blood. 
This implies that the influence of innate signaling mol-
ecules on the ability of the host to control an infectious 
process is more than simply the degree of inflammatory 
mediators produced. The G (minor) allele may have per-
sisted in the population because early inflammation may 
be important to control parasite replication during acute 
malaria infection, whereas hyperresponsiveness to other 
PAMPS is detrimental in other disease states (e.g. bacte-
rial sepsis).
Investigations into the role of TLR signalling in malaria 
infection using murine models have revealed conflict-
ing results. Both TLR1 and TLR6 signal via forming het-
erodimers with TLR2 [9, 10] All TLRs except for TLR3 
signal via the adaptor protein MyD88 and disruption in 
MyD88 and TLR2 disrupts signaling cascades generated 
by TLR1 and TLR6 [27]. During infection with Plasmo-
dium berghei ANKA strain (a model for cerebral malaria), 
Table 1 Demographic characteristics of enrolled patients
N 432
Age, mean (std dev) 27 (11.1)
Ethnicity, n (%)
 Thai 182 (41.8)
 Mon 126 (29.0)
 Karen 71 (16.3)
 Burma 53 (12.2)
 Cambodia 2 (0.5)
 Nepali 1 (0.2)
Table 2 Clinical characteristics of enrolled patients




% F % M Median (range)
Uncomplicated 257 25 (2–65) 32.3 67.7 7890 (13–422,400)
Severe 92 22 (12–59) 25.3 74.7 71,400 (350– 
 944,240)
Cerebral 86 26 (14–61) 19.4 80.6 95,790 (94– 
 1,188,720)
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Tlr2−/− and Myd88−/− mice have been shown by some 
groups to be protected from development of cerebral 
malaria, although the effects of TLR2 have not been con-
sistently observed and may depend on the genetic back-
ground of the mice [28–31]. Infection with Plasmodium 
yoelii, a model of acute uncomplicated malaria, had either 
a strong phenotype with impaired survival in Tlr2−/−, 
and Myd88−/− mice or no observable phenotypic dif-
ference [32, 33]. It is likely that there are multiple innate 
mechanisms that contribute to the host response against 
malaria infection, and single knockout inbred mice may 
not recapitulate the complexity of human disease.
In an effort to clarify the role of TLRs in human malaria, 
several studies have used genetic approaches attempting 
to detect associations between common genetic variants 
in the genes for TLRs and clinical outcomes in patients 
with malaria. In a group of malaria cases from northern 
Thailand with confirmed P. falciparum infection, none 
of the genetic variants tested were significantly associ-
ated with development of complicated malaria (Table 3), 
whereas increasing copy numbers of the major T allele 
of TLR1 rs5743551 demonstrated a trend towards higher 
odds of complicated disease (p = 0.13). Notably, while this 
polymorphism is in high linkage disequilibrium (LD) with 
TLR1 rs5743551 in Caucasian subjects, it was determined 
that in the Southeast Asian subjects from Northern Thai-
land that TLR1 rs5743618 is in very weak LD with TLR1 
rs5743551 and is found at very low frequency [14].
The finding that TLR1 rs5743618 is associated with 
higher parasitaemia on day zero in an Asian population 
is similar to an investigation by a Brazilian group that 
Table 3 Genotype associations
Gene Genotype Malaria type Parasitemia (day 0)
Uncomplicated Complicated OR (CI) p Mean β p
TLR1 rs5743551
 CC 59 (64.8) 32 (35.2) 1.26 (0.93–1.71) 0.14 57,224 (91,846) 0.16 0.042
 CT 107 (58.5) 76 (41.5) 73,597 (142,004)
 TT 44 (53.7) 38 (46.3) 106,744 (190,805)
rs5743614
 AA (Ser/Ser) 59 (62.8) 35 (37.2) 1.17 (0.86–1.59) 0.32 57,116 (89,419) 0.14 0.078
 AG (Ser/Ser) 110 (58.5) 78 (41.5) 73,087 (142,004)
 GG (Ser/Ser) 41 (55.4) 33 (44.6) 111,539 (198,734)
rs5743618
 TT (Ile/Ile) 202 (58.6) 143 (41.5) 1.41 (0.48–4.12) 0.53 79,114 (147,719) −0.03 0.91
 GT (Ser/Ile) 7 (50.0) 7 (50.0) 55,513 (73,399)
 GG (Ser/Ser) 0 0 –
TLR6 rs3775073
 TT (Lys/Lys) 55 (57.9) 40 (42.1) 0.89 (0.66–1.18) 0.42 87,461 (143,708) 0.07 0.35
 TC (Lys/Lys) 106 (63.1) 62 (36.9) 81,825 (167,173)
 CC (Lys/Lys) 49 (52.1) 45 (47.9) 61,273 (99,746)
rs5743808
 AA (Ile/Ile) 158 (58.5) 112 (41.5) 0.96 (0.62–1.48) 0.85 79,744 (150,930) −0.04 0.74
 GA (Thr/Ile) 47 (57.3) 35 (42.7) 73,177 (132,271)
 GG (Thr/Thr) 5 (71.4) 2 (28.6) 67,254 (77,658)
Fig. 2 Parasitaemia by TLR1 rs5743551 in major ethnic groups. Box 
plots represent the median (mid-box line), intra‑quartile range (upper 
and lower box margins), upper and lower values within ± 1.5 × intra‑
quartile range (upper and lower error bars), and outliers (blue filled 
circles) for parasitaemia measured on day 0 of enrollment by TLR1 
rs5743551 genotype
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demonstrated an association between the G allele of 
TLR1 rs5743618 and increased risk of developing symp-
tomatic malaria after infection with Plasmodium [33]. 
The Brazilian group did not genotype TLR1 rs5743551 
in their study, so direct comparisons between their study 
and the studied population cannot be made. However, 
taken together, these studies suggest that genetic varia-
tion in TLR1 affects host susceptibility to malaria disease 
severity, while variation in TLR6 is less likely to play a 
significant role in these processes. This association is fur-
ther supported by a study in a population in Cameroon 
that reported a different SNP in TLR1 (rs4833095) was 
also associated with increased parasite burden, whereas 
a SNP in TLR6 was not associated with any clinical phe-
notype [34].
Stronger evidence that TLR1 rs5743551 may influ-
ence host responses to malaria is provided by the 
finding of a significant association between the copy 
number of the T allele of this polymorphism and 
increased parasitaemia measured on day 0 of enroll-
ment. Subjects carrying the TT genotype had a nearly 
two-fold higher parasitaemia than subjects carrying the 
CC genotype (Table 3). Segregated analysis by ethnicity 
showed that the strongest effect of the T (minor) allele 
was present in the subjects of Mon ethnicity. This find-
ing differs from those of the Brazilian group who found 
no association between TLR1 variation and parasitae-
mia. In contrast, the population in Cameroon demon-
strated a similar association with TLR1 polymorphism 
associated with differences in parasite load. Explana-
tions for the differing findings may be due to the differ-
ent TLR1 variants tested but could also include marked 
differences in environment (Brazil versus Thailand), 
and underlying population genomic differences. Fur-
thermore, in the Brazilian study a substantial minority 
of patients were infected with P. vivax (39 %), whereas 
the population in Cameroon was similar to the stud-
ied population in that it was a population uniformly 
infected with P. falciparum. Several groups have dem-
onstrated different host response to the various Plas-
modium species. For example, higher levels of IL-10 
have been documented in humans subjects infected 
with Plasmodium vivax when compared to individuals 
infected with P. falciparum [31–33].
Conclusions
The particular strengths of the present study include 
detailed clinical information on a population uni-
formly infected with PCR confirmed P. falciparum. 
The current study is the first to document an associa-
tion of TLR1 rs5743551 with a clinical outcome in an 
Asian population with malaria. TLR6 has never been 
strongly implicated in the host response to malaria and 
no association with TLR6 SNPs and clinical outcome in 
malaria were found.
These data demonstrate that the G allele of rs5743551 
in TLR1 is associated with the host control of para-
sitaemia in Asian patients with acute febrile malaria. 
This assertion is consistent with the demonstrated abil-
ity of malarial GPI to activate cells through TLR2/TLR1 
heterodimers [4]. From an evolutionary standpoint, 
this suggests that G allele of TLR1 rs5743551 may per-
sist in higher frequencies in non-Caucasian populations 
because of a beneficial effect on host fitness in environ-
ments with high prevalence of malaria. This is the first 
plausible explanation for the relatively high frequency of 
an allele that is associated with worse outcomes in tuber-
culosis, sepsis, and leprosy [14–16]. While parasitaemia 
is generally correlated with complicated disease, high 
parasitaemia alone is neither necessary nor sufficient to 
account for poor patient outcomes and other host factors 
likely influence clinical outcomes [24]. These findings 
stress the complex interplay between the human genome 
and endemic pathogens.
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